Literature DB >> 27327262

The role of religion and spirituality in coping with kidney disease and haemodialysis in Thailand.

Kantaporn Yodchai1, Trisha Dunning2, Sally Savage3, Alison M Hutchinson4,5.   

Abstract

BACKGROUND: People with chronic kidney disease (CKD) face various problems including psychological, socioeconomic and physical effects associated with CKD and its treatment. They need to develop strategies to help them cope with CKD and life challenges. Religion and spirituality are important coping strategies, but their role in helping people cope with CKD and haemodialysis (HD) in Thailand is relatively unknown. AIMS: To investigate the role of religion and spirituality in coping with CKD and its treatment in Thailand.
DESIGN: An exploratory, qualitative approach was undertaken using semistructured individual interviews.
METHOD: Purposive sampling was used to recruit participants. Face-to-face, in-depth individual interviews using open questions were conducted during January and February 2012. Interviews were audio-recorded and transcribed verbatim. Data were analysed using the framework method of qualitative data analysis.
FINDINGS: Twenty people receiving HD participated: age range 23-77 years, mean 53.7 (±16.38 SD). Ten were women. Participants reported use of religious and spiritual practices to cope with CKD and its treatment, including religious and spiritual explanations for developing CKD, karmic disease, making merit, reading Dharma books, praying and chanting to save life and making a vow to Pran-Boon.
CONCLUSION: Religion and spirituality provide powerful coping strategies that can help Thai people with CKD overcome the associated distress and difficulties. Religion and spirituality cannot be separated in Thai culture because Thai people are both religious and spiritual.
© 2016 Nordic College of Caring Science.

Entities:  

Keywords:  Chronic Kidney Disease; Haemodialysis; Religion; Spirituality

Mesh:

Year:  2016        PMID: 27327262     DOI: 10.1111/scs.12355

Source DB:  PubMed          Journal:  Scand J Caring Sci        ISSN: 0283-9318


  7 in total

1.  Coping Strategies in End-Stage Renal Disease Patients on Hemodialysis in Oman: Optimistic, Supportive, Confrontive, and Prayerful.

Authors:  Amal Al Sharji; Fawwaz Alaloul; Basma Al Yazeedi
Journal:  J Relig Health       Date:  2022-05-16

2.  The Effect of Hajj Pilgrimage on Treatment Compliance in Individuals with Chronic Diseases.

Authors:  Feride Taskin Yilmaz; Selma Sabanciogullari; Gulseren Karabey
Journal:  J Relig Health       Date:  2019-04

3.  The Effect of Spirituality in Quality of Life of Hemodialysis Patients.

Authors:  Evangelos C Fradelos; Victoria Alikari; Konstantinos Tsaras; Ioanna V Papathanasiou; Foteini Tzavella; Dimitris Papagiannis; Sofia Zyga
Journal:  J Relig Health       Date:  2021-01-07

4.  Polyphenolic compounds of amla prevent oxidative stress and fibrosis in the kidney and heart of 2K1C rats.

Authors:  Md Mizanur Rahman; Khandoker Usran Ferdous; Shraboni Roy; Iffat Ara Nitul; Fariha Mamun; Md Hemayet Hossain; Nusrat Subhan; Md Ashraful Alam; Md Areeful Haque
Journal:  Food Sci Nutr       Date:  2020-05-20       Impact factor: 2.863

5.  What Are the Hemodialysis Patients' Style in Coping with Stress? A Directed Content Analysis.

Authors:  Mohtasham Ghaffari; Mohammad Ali Morowatisharifabad; Yadolah Mehrabi; Samad Zare; Jafar Askari; Somayeh Alizadeh
Journal:  Int J Community Based Nurs Midwifery       Date:  2019-10

6.  Factors associated with the use of complementary therapies in Taiwanese patients with systemic lupus erythematosus: a cross-sectional study.

Authors:  Ming-Chi Lu; Hui-Chin Lo; Hsiu-Hua Chang; Chia-Wen Hsu; Malcolm Koo
Journal:  BMC Complement Med Ther       Date:  2021-10-01

7.  Work of being an adult patient with chronic kidney disease: a systematic review of qualitative studies.

Authors:  Javier Roberti; Amanda Cummings; Michelle Myall; Jonathan Harvey; Kate Lippiett; Katherine Hunt; Federico Cicora; Juan Pedro Alonso; Carl R May
Journal:  BMJ Open       Date:  2018-09-04       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.